The global hydroxyapatite market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.92 billion by 2030, growing at a CAGR of 7.5% from 2025 to 2030. The market is witnessing strong growth, primarily driven by the rising demand for biocompatible materials across medical and dental applications. As healthcare systems increasingly adopt advanced regenerative medicine techniques, the utilization of hydroxyapatite in implants, coatings, and fillers has expanded significantly, owing to its exceptional compatibility with biological tissues.

The growing prevalence of orthopedic disorders such as osteoporosis, arthritis, and bone fractures—especially among the aging population—has further accelerated the demand for hydroxyapatite-based products. These materials are widely used in bone grafting and implant coatings to promote bone regeneration and enhance structural integrity. Additionally, the growing awareness of oral health and rapid advancements in dental treatment technologies are contributing to the rising adoption of hydroxyapatite in dental restorations. Its inclusion as a bioactive component in toothpaste and other dental care formulations supports enamel repair and tooth remineralization, adding to the market’s growth momentum.

Hydroxyapatite (HA) is a naturally occurring mineral form of calcium apatite, composed mainly of calcium and phosphorus, and represents the primary inorganic component of human bones and teeth. It provides strength, rigidity, and structure to skeletal and dental systems. Due to its high biocompatibility, osteoconductive characteristics, and chemical resemblance to natural bone, HA has become a critical material in biomedical applications such as bone grafts, dental implants, and coatings for orthopedic devices. Its porous microstructure facilitates bone cell attachment and growth, making it particularly suitable for medical implants that require seamless integration with surrounding bone tissue.

Beyond medical uses, hydroxyapatite is also gaining popularity in the cosmetics and oral care industries. In cosmetic formulations, it is used for skin regeneration and repair, while in dental care, it helps restore and strengthen tooth enamel, offering a natural and effective alternative to synthetic ingredients. With its wide-ranging applications and biocompatible nature, hydroxyapatite continues to play a vital role in advancing healthcare and personal care solutions globally.

Key Market Trends & Insights:

• The Asia-Pacific region dominated the global hydroxyapatite market, accounting for a revenue share of 50.7% in 2024. This strong regional presence is attributed to rapid advancements in the healthcare and dental care industries, growing awareness of bone and dental health, and increasing investments in medical infrastructure. Countries such as China, Japan, India, and South Korea are witnessing a rise in orthopedic and dental procedures, driven by a large aging population and higher healthcare spending. Additionally, the presence of several local manufacturers offering cost-effective hydroxyapatite products has further strengthened the region’s leadership position in the global market.

• Based on product type, the nano-sized hydroxyapatite segment held the largest market share, accounting for 58.3% of the total revenue in 2024. The dominance of this segment is primarily due to the superior properties of nano-sized hydroxyapatite, such as enhanced bioactivity, higher surface area, and improved interaction with biological tissues. These characteristics make it ideal for use in advanced medical and dental applications, including bone tissue engineering, implant coatings, and restorative dentistry. The increasing adoption of nanotechnology in the biomedical field and continuous research into nanoscale materials have further boosted the growth of this segment.

• By end-use, the orthopedics segment emerged as the leading application area, capturing a market share of 56.3% in 2024. This dominance is driven by the rising prevalence of bone-related disorders such as fractures, osteoporosis, and arthritis, along with an increasing number of joint replacement and spinal surgeries. Hydroxyapatite’s exceptional biocompatibility, osteoconductivity, and ability to support bone regeneration make it a preferred material in orthopedic implants, coatings, and bone graft substitutes. As the global demand for advanced orthopedic solutions continues to grow, the use of hydroxyapatite in this sector is expected to expand further in the coming years.

Order a free sample PDF of the Hydroxyapatite Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 2.54 Billion

• 2030 Projected Market Size: USD 3.92 Billion

• CAGR (2025-2030): 7.5%

• Asia-Pacific: Largest market in 2024

Key Companies & Market Share Insights:

Some of the key players in the hydroxyapatite market include APS Materials Inc. and Linde Plc, both of which are recognized for their technological expertise and specialized product offerings in biomedical applications.

APS Materials Inc., headquartered in the U.S., is a leading provider of advanced thermal spray coatings for a wide range of industries, including biomedical, aerospace, energy, and industrial sectors. The company is particularly well-known for its plasma spray technology, which is widely applied in hydroxyapatite coatings for orthopedic and dental implants. These coatings enhance biocompatibility and promote osseointegration, making implants more effective and durable. APS Materials offers customized solutions designed to improve wear resistance, corrosion protection, and thermal insulation. Its services cater to a global clientele, including medical device manufacturers, aviation companies, and industrial equipment producers, reflecting the company’s strong technical capabilities and broad market reach.

Berkeley Advanced Biomaterials (BAB), a subsidiary of GNI Group Ltd., is another major player specializing in the development and manufacturing of biomaterials for orthopedic, dental, and spinal applications. BAB focuses on calcium phosphate-based biomaterials, including hydroxyapatite and bone graft substitutes, which are extensively used in bone regeneration and repair procedures. The company emphasizes the production of high-quality, medical-grade materials that meet stringent global healthcare standards. BAB collaborates closely with medical device manufacturers, research institutions, and healthcare providers to support the development of advanced therapeutic solutions. Since its acquisition by GNI Group Ltd., a Japan-based biopharmaceutical company, BAB has expanded its research, production capabilities, and global market presence, strengthening its role as a key supplier of hydroxyapatite and related biomaterials for critical medical applications.

Key Players

• APS Materials Inc.

• Berkeley Advanced Biomaterials (GNI Group Ltd)

• Bio-Rad Laboratories Inc.

• CGbio

• Fluidinova

• The Lubrizol Corporation

• Granulab Sdn. Bhd.

• SigmaGraft Biomaterials

• Taihei Chemica Industrial Co. Ltd.

• Zimmer Biomet

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global hydroxyapatite market is experiencing robust growth, driven by the increasing demand for biocompatible materials in medical and dental applications. This surge is attributed to the rising prevalence of orthopedic disorders and dental issues, which necessitate advanced biomaterials for effective treatment. Hydroxyapatite's unique properties, such as its similarity to human bone and teeth, make it an ideal material for bone grafts, dental implants, and coatings for orthopedic devices.